This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Accountability Remove Biotechnology Remove Medical Technology Remove Prevention
article thumbnail

Protecting the Consumer at the Heart of DTC Precision Medicine

Bill Of Health

OCTOBER 27, 2023

The HIPAA Problem The privatization of next-generation medical technologies, especially in regenerative and precision medicine, further muddies the data-protection waters. The innovation-security tradeoff is a familiar trope in biotechnology, but the main character of the direct-to-consumer tissue-based service story is less so.

Biotechnology 62
Biotechnology Regulations Medical Services Health Data 62
article thumbnail

From Regulation to Innovation: The Impact of the EU AI Act on XR and AI in Healthcare

Bill Of Health

MAY 20, 2024

The EU’s AI Act sets rigorous standards for high-risk AI systems, emphasizing robust data quality, detailed record-keeping, and clear user information to ensure transparency and accountability. These reforms streamline liability claims and establish clearer accountability for AI-generated issues.

Regulations 44
Regulations Healthcare Biotechnology Accountability 44
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 19,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024